GR

Werner Sarlikiotis

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Sarlikiotis. Retrieved from https://idiyas.com/inventor/werner-sarlikiotis-s3olfc5h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Werner Sarlikiotis: Innovator in Injectable Solutions

Introduction

Werner Sarlikiotis is a notable inventor based in Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable solutions. His work focuses on enhancing the efficacy of treatments through innovative formulations.

Latest Patents

Currently, Werner Sarlikiotis holds no patents. However, he has developed a noteworthy patent for an injectable solution of an LHRH antagonist. This solution is an aqueous injectable formulation that includes Cetrorelix, combined with an organic, pharmaceutically acceptable acid such as gluconic acid.

Career Highlights

Werner Sarlikiotis is associated with Zentaris IVF GmbH, where he applies his expertise in pharmaceutical innovations. His work at the company emphasizes the development of advanced medical solutions that cater to specific health needs.

Collaborations

Throughout his career, Werner has collaborated with esteemed colleagues, including Horst Bauer and Mattias Rischer. These partnerships have contributed to the advancement of his research and the successful development of innovative products.

Conclusion

Werner Sarlikiotis is a dedicated inventor whose work in injectable solutions showcases his commitment to improving medical treatments. His contributions to the field, although currently without patents, reflect a promising future in pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…